Importance of the CuAAC Reaction in the Synthesis of Platinum Complexes with 1,4-Disubstituted-1H-1,2,3-triazoles: A Review of Their Anticancer Activity

• Published in: Reactions (Basel, Switzerland) Vol. 5; no. 4; pp. 947 - 983
• Main Authors: Hernández-Romero, Delia, Rosete-Luna, Sharon, Méndez-Bolaina, Enrique, Herrera-Cogco, Elena de la C., Amador-Gómez, Luis P., Soto-Contreras, Anell, Rivera-Villanueva, José M., Colorado-Peralta, Raúl
• Format: Journal Article
• Language: English
• Published: 24-11-2024
• ISSN: 2624-781X; 2624-781X
• DOI: 10.3390/reactions5040050

Despite multiple advances in treatment and prevention, cancer remains one of the leading causes of death worldwide. Chemotherapy remains the most effective method for cancer treatment. However, commercial chemotherapeutic drugs have limited efficacy, severe side effects, and acquired resistance. Therefore, the scientific community has devoted a great effort to designing new, more effective, and cheaper drugs. In this sense, copper-catalyzed azide-alkyne cycloaddition reactions (CuAAC) provide 1,4-disubstituted 1H-1,2,3-triazoles in high yields without forming by-products. This reaction allows the easy, efficient, functional, ordered, rapid, selective, and specific joining of small molecules, giving rise to more complex molecules. The CuACC reaction simplifies the synthesis processes, accelerating the discovery of new chemotherapeutic agents by allowing the joining of commercial platinum drugs, slightly altering their structure, or creating new molecules with improved properties. This work shows the importance of CuAAC reactions in the search for new metallodrugs with possible anticancer activity.